111 related articles for article (PubMed ID: 21644928)
1. ATF4 deficiency protects mice from high-carbohydrate-diet-induced liver steatosis.
Li H; Meng Q; Xiao F; Chen S; Du Y; Yu J; Wang C; Guo F
Biochem J; 2011 Sep; 438(2):283-9. PubMed ID: 21644928
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.
Miyazaki M; Flowers MT; Sampath H; Chu K; Otzelberger C; Liu X; Ntambi JM
Cell Metab; 2007 Dec; 6(6):484-96. PubMed ID: 18054317
[TBL] [Abstract][Full Text] [Related]
3. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
4. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
[TBL] [Abstract][Full Text] [Related]
5. Lipid Emulsion Added to a Liquid High-Carbohydrate Diet and Voluntary Running Exercise Reduce Lipogenesis and Ameliorate Early-Stage Hepatic Steatosis in Mice.
Huang KH; Hao L; Smith PB; Rogers CJ; Patterson AD; Ross AC
J Nutr; 2017 May; 147(5):746-753. PubMed ID: 28298542
[No Abstract] [Full Text] [Related]
6. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.
Purushotham A; Shrode GE; Wendel AA; Liu LF; Belury MA
J Nutr Biochem; 2007 Oct; 18(10):676-84. PubMed ID: 17368879
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
8. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
9. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation.
Li JZ; Ye J; Xue B; Qi J; Zhang J; Zhou Z; Li Q; Wen Z; Li P
Diabetes; 2007 Oct; 56(10):2523-32. PubMed ID: 17646209
[TBL] [Abstract][Full Text] [Related]
10. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
11. Diet-dependent alterations of hepatic Scd1 expression are accompanied by differences in promoter methylation.
Schwenk RW; Jonas W; Ernst SB; Kammel A; Jähnert M; Schürmann A
Horm Metab Res; 2013 Oct; 45(11):786-94. PubMed ID: 23803969
[TBL] [Abstract][Full Text] [Related]
12. Lipid redistribution by α-linolenic acid-rich chia seed inhibits stearoyl-CoA desaturase-1 and induces cardiac and hepatic protection in diet-induced obese rats.
Poudyal H; Panchal SK; Waanders J; Ward L; Brown L
J Nutr Biochem; 2012 Feb; 23(2):153-62. PubMed ID: 21429727
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
14. Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice.
Hu CC; Qing K; Chen Y
Obes Res; 2004 Aug; 12(8):1264-70. PubMed ID: 15340109
[TBL] [Abstract][Full Text] [Related]
15. The role of stearoyl-CoA desaturase in the control of metabolism.
Dobrzyn A; Ntambi JM
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):35-41. PubMed ID: 15941655
[TBL] [Abstract][Full Text] [Related]
16. Diet-induced obesity associated with steatosis, oxidative stress, and inflammation in liver.
Peng Y; Rideout D; Rakita S; Lee J; Murr M
Surg Obes Relat Dis; 2012; 8(1):73-81. PubMed ID: 21978752
[TBL] [Abstract][Full Text] [Related]
17. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein.
Yamazaki T; Kishimoto K; Miura S; Ezaki O
J Nutr Biochem; 2012 Feb; 23(2):123-32. PubMed ID: 21447441
[TBL] [Abstract][Full Text] [Related]
18. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism.
Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS
Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426
[TBL] [Abstract][Full Text] [Related]
19. Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis.
Nakatani M; Kokubo M; Ohsawa Y; Sunada Y; Tsuchida K
Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E543-53. PubMed ID: 21205933
[TBL] [Abstract][Full Text] [Related]
20. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
